secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2026-09-14T20:06:27+00:00
Accession:  0001193125-26-390562
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Teva begins trading ordinary shares on NYSE; ADS program terminated
-------------------------------------------------------------------

- Effective Sept 14, 2026, Teva ordinary shares trade on NYSE under 'TEVA', replacing ADSs.
- Each American depositary share exchanged for one ordinary share; ADS program terminated.
- Shares continue to trade on Tel Aviv Stock Exchange under same symbol 'TEVA'.
- Ticker unchanged, but security type changes from ADS to ordinary share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312526390562/0001193125-26-390562-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312526390562/d503082d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-390562

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer